U.S. FOOD SUPPLY SAFETY THREATENED TODAY WITH FDA APPROVAL OF CONTROVERSIAL
NEW ARTIFICIAL SWEETENER 13,000 TIMES SWEETER THAN SUGAR
DALLAS, July 5, 2002 - (Aspartame Consumer Safety Network) - In response to
FDA and Monsanto's announcement today that approval has been granted for use
of the new sweetener, Neotame as a food additive in baked goods, aqueous
solution and as a table top sweetener, Aspartame Consumer Safety Network,
issues the following statement:
Seventy eight percent of all FDA complaints pertain to aspartame adverse
reactions. ACSN has thousands of serious reactions in their files. These
reports include: grand mal seizures, brain tumors, blindness and other
health-related problems including deaths.
Monsanto's Nick Rosa stated in 1998, that Neotame is "based on the
aspartame formula." Since we believe this to be true, Dallas-based
Aspartame Consumer Safety Network vigorously opposes today's approval and
urges consumers to avoid the new fake sugar if they want to remain healthy.
Neotame is aspartame plus 3-di-methyl-butyl, which can be found on the EPA's
list of most hazardous chemicals. The aspartame formula is comprised of
Phenylalanine, which caused seizures in lab animals and Aspartic Acid, which
caused "holes in the brains" of lab animals - bonded by Methyl
Alcohol, or Methanol which is capable of causing blindness, liver damage and
death.
Methanol, or wood alcohol in aspartame breaks down further in heat and in the
body, into Formaldehyde (embalming fluid), Formic Acid (venom in ant stings)
and the most deadly of all - Diketopiperazine (DKP), a brain tumor
agent.ACSN's files contain in excess of 10,000 responses from the public,
including thousands of serious adverse reactions to Monsanto's aspartame.
As a founder of the world's burgeoning anti-aspartame movement, Stoddard was
the first non-M.D.engaged to lecture at a major medical school on the topic of
Aspartame (Jan. 1997).ACSN founder, Stoddard recently concluded a multi-city
lecture tour and finds interest in this topic to be extremely high - here and
all over the world. Recently, a story appeared in London's Sunday Mirror,
featuring an adverse reaction of a child whose parents are members of A.C.S.N.
(Aspartame Consumer Safety Network). Aspartame has been identified and
denounced as a major risk factor by consumers in over a dozen countries.
According to FDA Toxicologists who gave testimony with Stoddard in
1987 at a Senate Hearing on the subject - the tests to get aspartame approved
were falsified. Deaths of lab animals were covered up and went unreported.
Many criminal acts were committed and the perpetrators went unpunished.
Based on over a decade of epidemiological research and work with consumers and
health care professionals, Stoddard urgently implored the FDA to unequivocally
deny any form of approval of Neotame. ACSN's warnings fell on deaf ears when
Stoddard and co-founder, James Turner, Esquire met with top FDA officials in
Washington in 1998 to plead their case. Today, four years later, FDA approval
was announced in the national media.
______________________________________________________________________
Mary Nash Stoddard, Author, "Deadly Deception Story of Aspartame" [Odenwald
Press 1998] Founder, Aspartame Consumer Safety Network and Worldwide Pilots
Hotline (Division of ACSN) [1987] P.O. Box 780634 - Dallas TX 75378-0634
214-352-4268 - email: marystod@airmail.net
http://web2.airmail.net/
____________________________________________________________________________
Additional Contacts:
Blondell Anderson Center for Food Safety and Applied Nutrition (HFS-206) FDA,
200 C Street, SW, Washington, DC 20204
Ms. Laura M. Tavantino Office of Premarket Approval Center for Food Safety and
Applied Nutrition (HFS-206) FDA, 200 C Street, SW, Washington, DC 20204
___________________________________________________________________________
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration [Docket No. 98F-0052]
Monsanto Co.; Filing a Food Additive Petition
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
SUMMARY: The Food and Drug Administration (FDA) is announcing that Monsanto
Co. has filed a petition proposing that the food additive regulations be
amended to provide for the safe use of L- Phenylanlanine,N-[N-(3,3-dimethylbutyl)-L--aspartyl]-,1-methyl
ester for use as a tabletop sweetener. Monsanto Co. also proposes that this
additive be identified as neotame.
DATES: Written comments on the petitioner's environmental assessment by March
12, 1998.
ADDRESSES: Submit written comments to the Dockets Management Branch
(HFA-305), Food and Drug Administration, 12420 Parklawn Dr., rm. 1-23,
Rockville, MD 20857.
FOR FURTHER INFORMATION CONTACT: Blondell Anderson, Center for Food Safety and
Applied Nutrition
(HFS-206), Food and Drug Administration, 200 C St. SW., Washington, DC 20204,
202-418-3106.
SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic Act
(sec. 409(b)(5) (21 U.S.C. 348(b)(5))), notice is given that a food additive
petition (FAP
8A4580) has been filed by Monsanto Co., 5200 Old Orchard Rd., Skokie, IL
60077. The petition proposes to amend the food additive regulations in 21 CFR
part 172 to provide for the safe use of L-Phenylanlanine,N-[N-(3,3-dimethylbutyl)-L-
-aspartyl]-,1- methyl ester as a tabletop sweetener and for the additive to be
identified as neotame.The potential environmental impact of this action is
being reviewed. To encourage public participation consistent with regulations
promulgated under the National Environmental Policy Act (40 CFR 1501.4(b)),
the agency is placing the environmental assessment submitted with the petition
that is the subject of this notice on display at the Dockets Management Branch
(address above) for public review and comment. Interested persons may, on or
before March 12, 1998, submit to the Dockets Management Branch (address above)
written comments. Two copies of any comments are to be submitted, except that
individuals may submit one copy. Comments are to be identified with the docket
number found in brackets in the heading of this document. Received comments
may be seen in the office above between 9 a.m. and 4 p.m., Monday through
Friday. FDA will also place on public display any amendments to, or comments
on, the petitioner's environmental assessment without further announcement in
the Federal Register. If, based on its review, the agency finds that an
environmental impact statement is not required and this petition results in a
regulation, the notice of availability of the agency's finding of no
significant impact and the evidence supporting that finding will be published
with the regulation in the Federal Register in accordance with 21 CFR
25.40(c).
Dated: January 23, 1998. Laura M. Tarantino, Acting Director, Office of
Premarket Approval, Center for Food Safety and Applied Nutrition. [FR Doc.
98-3296 Filed 2-9-98; 8:45 am ] BILLING CODE 4160-01-F
Word Matches: NEOTAME
Archive-Name: gov/us/fed/nara/fed-register/1998/feb/10/63FR6762
Posting-number: Volume 63, Issue 27, Page 6762
[Federal Register: February 10, 1998 (Volume 63, Number 27)] [Notices] [Page
6762] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr10fe98-107]